Webinar Recording: Current Perspectives and Future Trends in Diversion Detection Webinar

Jenny HarlettBlog

Recently we hosted an online symposium around the topic of diversion detection. We were honored to have four fantastic hosts for each one-hour session: “A Comprehensive Drug Diversion Program: Top 10 Critical Components Every Institution Should Have” by Dr. Christopher Fortier, Pharm.D., FASHP, chief pharmacy officer, Boston, MA “Nursing Perspective on Diversion and Role in a Controlled Substance Diversion Program … Read More

2020 KLAS Category Leader — Drug Diversion Monitoring

Bluesight for Controlled Substances Named Category Leader in Best in KLAS 2020 Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We are thrilled to announce that Bluesight for Controlled Substances received the honor of Category Leader in Drug Diversion Monitoring Solutions, earning a rating of 93.9 out of 100! The annual Best in KLAS report analyzes data from customers to provide accurate perspective on the products … Read More

Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report

Jenny HarlettPress Release

KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering on product support, customer loyalty and quality of operations.   WASHINGTON (January 31, 2020) — Kit Check™, the leader in automated and intelligent medication management solutions, today announced that its Bluesight™ for Controlled Substances diversion detection software has been named the Category Leader in Drug Diversion … Read More

Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders

Jenny HarlettPress Release

Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical providers relating to controlled substances management and drug diversion WASHINGTON (January 14, 2020) – Kit CheckTM, the leader in automated and intelligent medication management solutions, today announced they will be hosting a first-of-its-kind continuing education online symposium, “Current Perspectives and Future Trends in Diversion Detection,” on … Read More

Big News: Kit Check Partners with Omnicell to offer BCS

Jenny HarlettBlog

We are very excited to announce that we have entered into an agreement with Omnicell to offer Bluesight for Controlled Substances to Omnicell customers! Through this new partnership, Omnicell customers will have access to a single sign-on dashboard that aggregates information from automated dispensing cabinets and the EMR, documenting who is handling what medications, when, where, and for whom.  This … Read More

Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis

Jenny HarlettBlog, News

The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny. Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play. … Read More

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Jenny HarlettPress Release

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 WASHINGTON (August 20, 2019) — Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances (Bluesight) diversion prevention and controlled substance management solution has been recognized by leading analyst firm KLAS Research in its next-generation solution … Read More

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More

Webinar: The Diversion Gap and What to Do About It

Jenny HarlettBlog

Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what we call the diversion gap—the space between controlled substance dispense activity and documentation where inventory can go missing. Hosted by IHFDA, the webinar covers key findings from our 2018 Hospital Pharmacy Operations Report, especially as they relate to the opioid crisis. AJ discusses the need … Read More

Nurses Unite: Impacting Change Around the Opioid Epidemic

Jenny HarlettBlog

This week we come together to celebrate the bravery, compassion, and determination of nurses. There are currently more than four million nurses practicing in the United States, and they are some of the most trusted professionals across any industry. Amid today’s opioid epidemic, which has claimed the lives of over 70,000 Americans, the American Nurses Association (ANA) recognizes the critical … Read More

CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft

Ava MutchlerBlog

As a member of the Forbes Technology Council, Kevin MacDonald recently penned an article on how AI technology can prevent opioid theft for the website’s Innovation section. In the Forbes article, MacDonald explains the why preventing diversion is a difficult problem for hospitals and how artificial intelligence can help to solve it.

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances

Jenny HarlettBlog

Data science has emerged as an ally for hospital directors of pharmacy in the continuous effort to close the “diversion gap”—the space where tracking and controls are incomplete and diverters conceal their activity. Simple math such as standard deviation and averages have proven inadequate in identifying controlled substance diverters who have become adept at covering their tracks. However, new machine … Read More